- Ertugliflozin
-
- $9.80 / 1.79999995231628KG
-
2020-01-09
- CAS:1210344-83-4
- Min. Order: 1g
- Purity: ≥99%
- Supply Ability: 100kg
|
| | Ertugliflozin L-pyroglutamic acid Basic information |
| Product Name: | Ertugliflozin L-pyroglutamic acid | | Synonyms: | PF-04971729 L-pyroglutamic acid;Ertugliflozin L-pyroglutamic Acid (1:1);ERTUGLIFLOZIN PIDOLATE;Pidolate;PF-04971729 ((S)-5-oxopyrrolidine-2-carboxylic acid);(1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol (1:1) compound with (S)-5-oxopyrrolidine-2-carboxylic acid;(S)-5-Oxopyrrolidine-2-carboxylic acid compound with (1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol (1:1);Gliadine L- pyroglutamate | | CAS: | 1210344-83-4 | | MF: | C27H32ClNO10 | | MW: | 566 | | EINECS: | | | Product Categories: | | | Mol File: | 1210344-83-4.mol |  |
| | Ertugliflozin L-pyroglutamic acid Chemical Properties |
| storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | DMSO: ≥ 125 mg/mL (220.85 mM) |
| | Ertugliflozin L-pyroglutamic acid Usage And Synthesis |
| Uses | Ertugliflozin L-pyroglutamic Acid is a reagent in the synthesis of Ertugliflozin (1210344-57-2) a sodium/glucose cotransporter 2 (SGLT2) inhibitor used to treat type 2 diabetes. |
| | Ertugliflozin L-pyroglutamic acid Preparation Products And Raw materials |
|